Symbol="CCCC"
AssetType="Common Stock"
Name="C4 TherapeuticsÂ Inc"
Description="C4 Therapeutics, Inc., a biopharmaceutical company, develops new therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1662579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="490 ARSENAL WAY, SUITE 200, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="178592000"
EBITDA="-132477000"
PERatio="None"
PEGRatio="None"
BookValue="5.35"
DividendPerShare="0"
DividendYield="0"
EPS="-2.69"
RevenuePerShareTTM="0.556"
ProfitMargin="0"
OperatingMarginTTM="-4.941"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.419"
RevenueTTM="27201000"
GrossProfitTTM="-86745000"
DilutedEPSTTM="-2.69"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.509"
AnalystTargetPrice="19.73"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="8.15"
PriceToBookRatio="1.208"
EVToRevenue="3.285"
EVToEBITDA="-1.541"
Beta="2.022"
num_52WeekHigh="13.23"
num_52WeekLow="2.6"
num_50DayMovingAverage="3.387"
num_200DayMovingAverage="5.43"
SharesOutstanding="49063800"
DividendDate="None"
ExDividendDate="None"
symbol="CCCC"
open="3.67"
high="3.68"
low="3.60"
price="3.64"
volume="268458.00"
latest_trading_day="2023-08-03"
previous_close="3.66"
change="-0.02"
change_percent="-0.5464%"
aroon_positive_momentum_days="23"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="23"
Volume_recent_avg="992515"
Change_recent_avg="-0.02"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.63"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="23"
Aroon_momentum_negative="77"
image_negative_thumbnail_id_1="102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_negative_thumbnail_id_2="1134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="1003"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
